53
Growth Score
pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Perseid Therapeutics LLC was founded in September 2009 as a joint venture between Maxygen, Inc.
John Borkholder: Chief Corporate Counsel
About the Company
Perseid Therapeutics LLC was founded in September 2009 as a joint venture between Maxygen, Inc. and Astellas Pharma Inc. to co-develop Maxygen's technology assets in protein pharmaceuticals, including MAXY-4, a next-generation CTLA4-Ig. Under the terms of the agreement, Astellas received worldwide rights to commercialize MAXY-4 for autoimmune
disease and transplantation.
